Skip to content

AARD AARD Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

AbbVie logo
AbbVieABBV
$34.11B+9.4%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$6.05M+173%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$119M-28.3%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: AARD’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's other non-current liabilities?
AARD (AARD) reported other non-current liabilities of $0 in Q4 2025.
How has AARD's other non-current liabilities changed year-over-year?
AARD's other non-current liabilities decreased by 100.0% year-over-year, from $26K to $0.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.